HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A highly active (102) surface-induced rapid degradation of a CuS nanotheranostic platform for in situ T1-weighted magnetic resonance imaging-guided synergistic therapy.

Abstract
Polyvinylpyrrolidone-modified CuS nanocrystals (CuS NCs) with high photothermal conversion efficiency (46%) and pH and near-infrared (NIR) light-triggered degradation properties are a promising nanotheranostic platform for in situ magnetic resonance imaging (MRI)-guided synergistic photothermal and photodynamic therapy. On the one hand, the (102) surface of CuS NCs has a small bandgap based on density functional theory, which leads to high photothermal conversion efficiency. On the other hand, the S vacancy formation energy of the (102) surface is favourable. On entry into tumor cells through endocytosis, the S2- ions on the (102) surface of CuS NCs can be easily oxidized under the tumor microenvironment and 808 nm laser irradiation; then, a large amount of Cu+ ions can be released from CuS NCs and accelerate the degradation of nanocrystals. Cu+ ions can generate reactive oxygen species (ROS) under the tumor microenvironment and 808 nm laser irradiation. Meanwhile, the oxidation product Cu2+ ions can be generated from the oxidized Cu+ ions and applied for in situ T1-weighted magnetic resonance imaging. Moreover, the biodegradable CuS NCs possess a high tumor uptake and can be rapidly excreted with a low long-term retention/toxicity. Therefore, degradable and multifunctional CuS NCs are a safe and efficient candidate for the diagnosis and treatment of cancer.
AuthorsLile Dong, Kai Li, Ding Wen, Yu Lu, Kaimin Du, Manli Zhang, Xuan Gao, Jing Feng, Hongjie Zhang
JournalNanoscale (Nanoscale) Vol. 11 Issue 27 Pg. 12853-12857 (Jul 21 2019) ISSN: 2040-3372 [Electronic] England
PMID31265050 (Publication Type: Journal Article)
Chemical References
  • Copper
  • cupric sulfide
Topics
  • Animals
  • Copper (chemistry, pharmacology)
  • HeLa Cells
  • Humans
  • Hyperthermia, Induced
  • Magnetic Resonance Imaging
  • Mice
  • Nanoparticles (chemistry, therapeutic use)
  • Neoplasms, Experimental (diagnostic imaging, metabolism, therapy)
  • Photochemotherapy
  • Phototherapy
  • Theranostic Nanomedicine
  • Tumor Microenvironment (drug effects)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: